ePoster

CONVERGENT DYSREGULATION OF THE UBIQUITIN PROTEASOME SYSTEM IN <EM>FMR1</EM><SUP>-/Y</SUP> RATS

Scott Murray Corsand 2 co-authors

University of Edinburgh

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS06-09PM-103

Presentation

Date TBA

Board: PS06-09PM-103

Poster preview

CONVERGENT DYSREGULATION OF THE UBIQUITIN PROTEASOME SYSTEM IN <EM>FMR1</EM><SUP>-/Y</SUP> RATS poster preview

Event Information

Poster Board

PS06-09PM-103

Abstract


In the developing and adult brain, synapses undergo constant remodeling—regulated by a complex interplay between local protein synthesis and degradation. In Fragile X Syndrome (FXS), protein synthesis and degradation rates are elevated, leading to a pathological shift in the synaptic proteome that causes synaptic dysfunction. Inhibiting protein synthesis reliably corrects FXS-associated phenotypes in preclinical models, but drugs targeting upstream regulators of protein synthesis have largely failed in clinical trials—prompting investigations into alternative treatment targets. Recently, we found that inhibiting the proteasome using bortezomib (BTZ) corrects protein synthesis rates and seizures in Fmr1 KO mice. However, it remains unknown which targets are corrected by BTZ and also if UPS function is affected in other FXS models. Here, we combined biochemical and proteomics from tandem ubiquitin binding entity (TUBE) pull downs from Fmr1 KO rat hippocampal slices and found convergent changes in UPS function. Future experiments will reveal if normalizing degradation rates of these conserved targets is sufficient to correct FXS-associated pathophysiology.

Recommended posters

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.